BMO Capital analyst John McNulty raised the firm’s price target on Ingevity (NGVT) to $62 from $61 and keeps a Market Perform rating on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback